Epineuron, a medical device company specializing in bioelectronic medicine, has received FDA clearance for the Evala Nerve Stimulator.
The handheld, intraoperative electrical stimulation device is engineered to provide surgeons with a rapid and accurate solution for nerve identification and functional evaluation of different nerve sizes. The approval expands the company’s portfolio and commercial footprint of its proprietary bioelectronic platform for peripheral nerve care.
Dr. Jana Dengler, MD, MASc, MHSc, a peripheral nerve surgeon at the renowned Sunnybrook Health Sciences Centre in Toronto, Ontario, was among the early users of Evala.
“I am impressed with the versatility of the product allowing me to evaluate nerves in scarred revision surgeries, nerve transfers, under extended tourniquet time, and in conjunction with PeriPulse,” she said.
"At Epineuron, we’ve listened closely to surgeons that expressed a significant need for more than just nerve stimulation hardware, they needed a cohesive ecosystem for nerve care," said CEO Sergio Aguirre in a statement. "We’ve broadened our technology by complementing PeriPulse with Evala to support surgeons during the most demanding aspects of a procedure. Whether it’s protecting nerves in real-time or boosting their regenerative capacity afterward, our technology integrates seamlessly into the surgical workflow to enhance efficiency and offer patients the best path to recovery."
